NEW YORK ─ The US Food and Drug Administration in November granted a few 510(k) clearances for in vitro diagnostic companies, according to the agency's website.
The diagnostics division of Basel, Switzerland-based Roche got the green light for its Cobas u 701 analyzer, a fully automated stand-alone urine analysis system optimized for high-volume laboratories.